Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma

In diffuse large B-cell lymphoma (DLBCL) treatment response relies on imaging. We investigated the potential value of molecular measurable residual disease (MRD) on circulating tumor DNA (ctDNA) to predict patient outcomes. We retrospectively evaluated 73 patients. Analyses were conducted on 57 t...

Description complète

Détails bibliographiques

Auteurs principaux:	Roberta Soscia, Giovanni Manfredi Assanto, Irene Della Starza, Riccardo Moia, Donatella Talotta, Vittorio Bellomarino, Teresa Bellissimo, Marco Antonacci, Luigi Petrucci, Gianluca Gaidano, Anna Guarini, Maurizio Martelli, Alice Di Rocco, Robin Foà, Ilaria Del Giudice
Format:	Artigo
Langue:	Inglês
Publié:	Ferrata Storti Foundation 2024-12-01
Collection:	Haematologica
Accès en ligne:	https://haematologica.org/article/view/11878
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!